We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-5.64%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$741B
AUM Growth
-$68.4B
Cap. Flow
-$3.25B
Cap. Flow %
-0.44%
Top 10 Hldgs %
15.48%
Holding
8,434
New
238
Increased
3,520
Reduced
3,560
Closed
255

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$2.61B
2
EPAM icon
EPAM Systems
EPAM
+$1.48B
3
TWLO icon
Twilio
TWLO
+$1.35B
4
AAPL icon
Apple
AAPL
+$1.24B
5
TWTR
Twitter, Inc.
TWTR
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 18.53%
2 Healthcare 9.76%
3 Financials 9.11%
4 Consumer Discretionary 8.41%
5 Communication Services 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALPN
6226
DELISTED
Alpine Immune Sciences Inc
ALPN
$83K ﹤0.01%
9,277
+132
+1% +$1.14K
PGAL
6227
DELISTED
Global X MSCI Portugal ETF
PGAL
$83K ﹤0.01%
7,530
RPT.PRD
6228
DELISTED
RPT Realty 7.25% Series D Cumulative Convertible Perpetual Preferred Shares of Beneficial Interest
RPT.PRD
$83K ﹤0.01%
1,378
+753
+120% +$43.4K
BIOTU
6229
DELISTED
Biotech Acquisition Company Unit
BIOTU
$83K ﹤0.01%
8,447
BMEA icon
6230
Biomea Fusion
BMEA
$92.8M
$82K ﹤0.01%
18,360
-8,669
-32% -$56.2K
FINW icon
6231
FinWise Bancorp
FINW
$190M
$82K ﹤0.01%
4,759
-3,461
-42% -$62.6K
ROI
6232
DELISTED
RiskOn International, Inc. Common Stock
ROI
$82K ﹤0.01%
1,188
+825
+227% +$61.3K
SGTX
6233
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$82K ﹤0.01%
4,305
-26,156
-86% -$583K
ZNTE
6234
DELISTED
Zanite Acquisition Corp. Class A Common Stock
ZNTE
$82K ﹤0.01%
8,040
-1,847
-19% -$18.9K
BFEB icon
6235
Innovator US Equity Buffer ETF February
BFEB
$259M
$81K ﹤0.01%
2,500
DRTS icon
6236
Alpha Tau Medical
DRTS
$1.31B
$81K ﹤0.01%
+6,850
New +$80.5K
ITRM
6237
DELISTED
Iterum Therapeutics
ITRM
$81K ﹤0.01%
15,082
+2,101
+16% +$12.1K
NNBR icon
6238
NN Inc
NNBR
$298M
$81K ﹤0.01%
28,249
-57,120
-67% -$188K
NVVE
6239
DELISTED
Nuvve Holding Corp
NVVE
0
RDOG icon
6240
ALPS REIT Dividend Dogs ETF
RDOG
$11.3M
$81K ﹤0.01%
1,585
+365
+30% +$18.2K
LJAQU
6241
DELISTED
LightJump Acquisition Corporation Unit
LJAQU
$81K ﹤0.01%
8,129
-5,857
-42% -$58.6K
EGPT
6242
DELISTED
VanEck Egypt Index ETF
EGPT
$81K ﹤0.01%
3,771
-500
-12% -$12.5K
HBIO icon
6243
Harvard Bioscience
HBIO
$30.4M
$80K ﹤0.01%
1,286
-570
-31% -$33.7K
OPTT icon
6244
Ocean Power Technologies
OPTT
$55.4M
$80K ﹤0.01%
56,717
-26,584
-32% -$33.9K
POLA icon
6245
Polar Power
POLA
$6.93M
$80K ﹤0.01%
3,592
-34
-0.9% -$767
AAC
6246
DELISTED
Ares Acquisition Corporation
AAC
$80K ﹤0.01%
8,205
+8,204
+820,400% +$80K
BLSA
6247
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$80K ﹤0.01%
8,095
+3,276
+68% +$32.2K
SCNI
6248
Scinai Immunotherapeutics
SCNI
$1.24M
$79K ﹤0.01%
476
+40
+9% +$5.81K
UFO icon
6249
Procure Space ETF
UFO
$634M
$79K ﹤0.01%
3,067
-761
-20% -$19K
AWRE icon
6250
Aware
AWRE
$26.4M
$78K ﹤0.01%
25,961
+25
+0.1% +$77

Similar funds

Morgan Stanley's Q1 2022 Portfolio in Review

As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
  • Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
  • Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
  • Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
  • Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
  • Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
  • Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.